UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Microsoft
MSFT
|
+$2.79B |
| 2 |
Meta Platforms (Facebook)
META
|
+$419M |
| 3 |
PPD
PPD, Inc. Common Stock
PPD
|
+$215M |
| 4 |
TAL Education Group
TAL
|
+$202M |
| 5 |
Intuit
INTU
|
+$190M |
Top Sells
| 1 |
Alibaba
BABA
|
+$1.6B |
| 2 |
NetEase
NTES
|
+$237M |
| 3 |
Goldman Sachs
GS
|
+$159M |
| 4 |
Baidu
BIDU
|
+$112M |
| 5 |
IAC Inc
IAC
|
+$108M |
Sector Composition
| 1 | Technology | 24.44% |
| 2 | Consumer Discretionary | 14.2% |
| 3 | Healthcare | 13.11% |
| 4 | Financials | 11.12% |
| 5 | Communication Services | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
CRISPR Therapeutics
CRSP
$5.08B
| $10.1M | 0.01% |
120,592
-18,438
| -13% | -$1.54M |
|
902
Webster Financial
WBS
$10.3B
| $10M | 0.01% |
379,564
+1,576
| +0.4% | +$41.6K |
|
903
LPL Financial
LPLA
$27.4B
| $10M | 0.01% |
130,585
-208
| -0.2% | -$15.9K |
|
904
First American
FAF
$6.93B
| $10M | 0.01% |
196,524
+2,475
| +1% | +$126K |
|
905
Murphy USA
MUSA
$7.26B
| $9.98M | 0.01% |
77,771
+39,536
| +103% | +$5.07M |
|
906
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$3.72B
| – | – |
0
| – | -$8.65M |
|
907
Lamar Advertising Co
LAMR
$12.8B
| $9.95M | 0.01% |
150,383
+8,666
| +6% | +$573K |
|
908
HUTCHMED
HCM
$2.7B
| $9.93M | 0.01% |
307,495
+66,476
| +28% | +$2.15M |
|
909
Cirrus Logic
CRUS
$5.91B
| $9.88M | 0.01% |
146,419
+11,708
| +9% | +$790K |
|
910
Allogene Therapeutics
ALLO
$260M
| $9.82M | 0.01% |
260,344
+13,933
| +6% | +$525K |
|
|
LSXMA
911
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $9.73M | 0.01% |
399,168
+10,642
| +3% | +$259K |
|
912
BioNTech
BNTX
$25.1B
| $9.71M | 0.01% |
140,192
-62,014
| -31% | -$4.29M |
|
913
Royal Gold
RGLD
$12.3B
| $9.66M | 0.01% |
80,394
-190
| -0.2% | -$22.8K |
|
|
DEA
914
Easterly Government Properties
DEA
$1.06B
| $9.62M | 0.01% |
171,722
+25,358
| +17% | +$1.42M |
|
915
Invesco S&P 500 Equal Weight ETF
RSP
$75.3B
| $9.62M | 0.01% |
+88,962
| New | +$9.62M |
|
916
Polaris
PII
$3.29B
| $9.59M | 0.01% |
101,695
+2,197
| +2% | +$207K |
|
917
Iovance Biotherapeutics
IOVA
$876M
| $9.55M | 0.01% |
290,057
-15
| -0% | -$494 |
|
918
Avnet
AVT
$4.52B
| $9.49M | 0.01% |
367,357
-668
| -0.2% | -$17.3K |
|
919
Liberty Broadband Class A
LBRDA
$8.61B
| $9.49M | 0.01% |
66,903
+15,369
| +30% | +$2.18M |
|
|
JOBS
920
DELISTED
51job, Inc.
JOBS
| $9.44M | 0.01% |
121,038
+26,718
| +28% | +$2.08M |
|
921
Exelixis
EXEL
$10.1B
| $9.36M | 0.01% |
382,857
+10,551
| +3% | +$258K |
|
|
BERY
922
DELISTED
Berry Global Group, Inc.
BERY
| $9.31M | 0.01% |
209,883
-103,088
| -33% | -$4.57M |
|
923
Encompass Health
EHC
$12.8B
| $9.31M | 0.01% |
180,046
+941
| +0.5% | +$48.6K |
|
924
Hanesbrands
HBI
$2.21B
| $9.3M | 0.01% |
590,628
-112,708
| -16% | -$1.78M |
|
925
Hanover Insurance
THG
$6.37B
| $9.29M | 0.01% |
99,716
-75,183
| -43% | -$7.01M |
|